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ABSTRACT: Aglaia roxburghiana is a traditional remedy for a variety of diseases.  The 
ethanolic extract of the leaves was screened for related activities were upon it exhibited 
significant anti-inflammatory activity in rats in acute and chronic models.  There was no acute 
toxicity in mice upto 2g/kg.  The extract protected the mast cell deregulation by compound 48/80 
and inhibited histamine induced contractions in guinea pig ileum.  The data obtained in this 
study suggest that the extract ma act by stabilizing mast cells ad blocking histamine receptors.  
 
INTRODUCTION  
 
Aglaia roxburghiana (W. &A) Miq. Var. 
beddomei (Meliaceae) is a source drug for 
Priyangu, used in Ayurveda (1). The plant is 
considered as a remedy for dysentery, skin 
diseases, leprosy, inflammation, leucoderma 
and abdominal pain (2), (3).  It is said to be 
cooling and useful in buring sensation of the 
body and painful maturation (4). 
 
There is no detailed literature pertaining to 
biological studies on the leaves of this plant.  
Hence the ethanolic extract of the leaves, 
which was found to have alkaloids, steroids 
and triterpeneoids (5), (6) has been 
considered for the present stud to evaluate 
the specific activities, if an, before 
investigation the isolated compounds.  
 
MATERIALS AND METHODS  
 
The leaves of Agalaia roxburghiana were 
freshly collected from Tirupathi ills in 
Andhra Pradesh and authenticated by the 
botanist, Captain Srinivasa Murti Drug 
Research Institute for Ayurveda, where a 
voucher specimen has been deposited.  
 
Shade dried and coarsely powdered leaves 
(2 kg) were extracted wit 90% alcohol by 
cold percolation method.  Te solvent was 
removed by distillation over water bat and 
races under vacuum.  This extract, 
designated as LF (yield 72.7g) was 
suspended in carboxymethyl cellulose 
(CMC) and used for animal experiments. 
 
Swiss albino mice (0-25g) Wistar albino rats 
(150 – 200g), guinea pigs (400-500g) were 
used for various experiment. 
 
Preliminary screening and acute toxicity 
testing  
 
Mice were tested with different doses of LF 
extract (500-4000 mg / kg, S.C) and 
continuously observed for 6h. The changes 
in various autonomic and behavioral 
responses were noted.  The animals were 
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kept under observation for a further period 
of 24h and mortality, if an, was noted, based 
on the results of preliminary screening (7) 
three doses (100, 200 & 400 mg/kg, s.c) 
were selected for further experiments. 
 
Analgesic activity  
 
This was investigated in mice using acetic 
cid induced writhing (8). Morphine sulphate 
(0.25 mg/kg, s.c) was used for comparison. 
 
Anti-inflammatory activity 
 
A) Acute study (i) Carrageenin induced 
hind-paw oedema in rats (9).  Different 
groups of rats were tested with there doses 
of LF extract. O.I ml of 1% carragenin was 
injected into the right hind paw 30 min after 
LF extract administration.  The paw volume 
was measured plethysmographically 5h after 
carrageenin injection. 
 
B) Chronic study (10) 
 
Sterile cotton- Pellets (10mg) were 
implanted s.c in arm – pits and groins in 
albino rats.  The animals were treated with 
LF extract for 7 days. 
 
All the animals were sacrificed on 8
th day 
and cotton- pellets were removed, dried at 
50
oC for 24 h and weighed. 
 
In the acute and chronic models of 
inflammation, the activity of LF extract was 
compared with Ibuprofen (100mg/kg, s.c) 
 
Mast cell degranulation (in vitro study) 
 
This was carried out by the modified method 
of Kaley & Weiner (ii). Lf extract was 
added to the incubates o produce a 
concentration of 1,10or 100 µg/ ml.  After 
10 in the mast degranulator compound 48/80 
(10 µg/ ml) was added and incubated for 
further 10 min. the percentage degranulation 
was calculated.  Te effect of LF extract per 
se was studied in separate mesenteric bits 
and percentage degranulation was 
calculated.  Disodium cromoglycate 
(DSCG) 1µg/ ml was included in the study 
for comparison. 
 
Gastric secretion and ulcer:  
 
Shay rat ulcer 
 
Adult male albino rats (130-150g) were 
selected and ulcers were induced as 
described y say et al (12).  The animals were 
treated with LF extract 30 min. prior to 
pyloric ligation.  A separate group of 
animals received aspirin 100 mg/kg (p.o) 60 
min prior to pyloric ligation. 
 
The animals were sacrificed 18h later. Ten 
the volume, free and total acidity of gastric 
contents were examined.  The gastric ulcers 
were scored and subjected to 
histopathological examination. 
 
Intestinal smooth muscle (in vitro) 
 
Health adult guinea pig starved overnight 
was sacrificed, the terminal ileum was cut, 
washed, mounted.  The contractions were 
recorded with histamine according to the 
method of ghosh (13).  Following this the 
LF extract was added and contractions were 
recorded.  The effect of LF extract on the 
spasmogenic effect of histamine was also 
investigated. 
 
Statistical analysis  
The results were analysed by analysis of 
variance followed by dunett’s test.  
 
RESULTS 
 
Preliminary screening and acute toxicity 
 
pages 52 - 57  3
There was no significant change in the 
various autonomic and behavioral responses 
after LF extract administration compared to 
the control animals.  No mortality was 
recorded in 24h in the animals treated with 
LF extract upto a dose of 2.0 g/kg. 
 
Analgesic activity 
 
Treatment with LF extract did not alter the 
number of acetic acid induced writhings in 
mice compared to vehicle treated animals,   
But, morphine treatment significantly 
reduced the number of writings in mice. 
 
Anti-inflammatory activity 
 
A) Acute study: In carrageenin induced 
paw oedema ibuprofen produced a 
significant reduction in paw oedema.   
Similarly a dose dependent reduction 
was observed wit different doses of LF 
extract (Tale-1). 
 
B)  Chronic study: A dose dependent 
reduction in the weigh of the cotton- 
pellects was observed after LF extract 
administration.  Te reduction was 
significant in all the doses tested (Table 
– 2) and comparable wit Ibuprofen. 
 
Effect on mast cell 
 
Compound 48/80 per se produced extensive 
degranulation of mast cells. Pre treatment 
with LF extract reduced this degranulation 
significantly at 10& 100 µg/ ml (Table -3). 
 
Effect on gastric secretion and ulcer 
 
Treatment wit a potent histamine (H2) 
antagonist, ranitidine significantly reduced 
the volume of gastric secretion, free acidity, 
total acidity and also the ulcer score 
compared to vehicle treatment in pyloric 
ligated rats. Treatment with LF extract 
reduced only the volume but there was not 
protection of ulcer by the different doses of 
the exact.  Histopathological examination 
revealed extensive ulceration after LF 
extract treatment and confirmed the above 
results. 
 
Effect on isolated guinea pig ileum 
 
LF extract per se did not produce any 
significant effect on the intestinal smooth 
muscle.  A dose dependent reduction in 
histamine response was observed after 
treatment with LF extract.   
 
Discussion 
 
The experiments designed in the present 
study were based on traditional claims.  The 
results of the stud, supports the traditional 
claims of the use of Aglaia roxburghiana in 
inflammation. 
 
A significant anti- inflammatory effect was 
observed in acute and chronic modes of 
inflammation as indicated by reduction in 
the paw oedema and cotton-pellet 
granuloma.  But the extract did not reveal an 
analgesic activity. 
 
The leaves contain alkaloids, triterpenes and 
steroids. The results of the present study 
supports the traditional claim of the plant in 
inflammation which suggests that one or a 
combination of the above said compounds 
present in the extract may be responsible for 
the above said activity. 
 
The probable mode of action may be by 
stabilization of mast cells and blocking the 
histamine receptor action, However, other 
mediators involvement needs to be explored 
in future studies. 
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Table 1 
Effect of Aglaia roxburghiana on acute inflammation 
 
Treatment (mg/kg)  Vol. of paw oedema (ml) 
Vehicle 
Ibuprofen 100 
LF extract 
100 
200 
400 
0.73 ± 0.04 
0.43 ± 0.04* 
 
0.37 ± 0.06* 
0.38 ± 0.06* 
0.33 ± 0.04* 
 
 *p<0.05 (Dunett’s test) 
Each value represents the mean ± SEM of 6 observations 
 
 Table 2 
Effect of Aglaia roxburghiana on Chronic inflammation 
 
Treatment (mg/kg; s.c)  Wt. of Cotton pellets (mg) 
Vehicle 
Ibuprofen 100 
LF extract 
100 
200 
400 
48.73 ± 7.05 
23.25± 1.36* 
 
37.40 ± 1.8* 
32.60 ± 1.0* 
22.65 ± 0.9* 
 
 *p<0.05 (Dunett’s test) 
Each value represents the mean ± SEM of 6 observations 
 
Table 3 
Effect of Aglaia roxburghiana on compound 48/80- induced degranulation of mast cells 
 
Pre-treatment (µg/ ml)  Treatment (µg/ ml)  % degranulation  
Vehicle 
Vehicle 
   LF extract 
1 
10 
100 
       DSCG1 
Vehicle 
48/80 -10 
 
48/80 -10 
48/80 -10 
48/80 -10 
48/80 -10 
21.8 ± 1.51 
66.0 ± 1.15 
 
66.0 ± 1.7 
55.0 ± 2.31* 
43.6 ± 1.9* 
20.0 ± 1.9* 
 
 *p<0.05 (Dunett’s test, Compared with vehicle + 48/80 treatment)) 
Each value represents the mean ± SEM of 6 observations 
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